| Members |
targetComponentId |
| Drugs used in infections |
Anti-infective agent (substance) |
| Drugs used in malignant disease and for immunosuppression |
Immunosuppressant (substance) |
| Drugs used in megaloblastic anemias |
Haematinic |
| Drusen |
Hyaline body |
| Duct contrast radiography NOS |
Plain X-ray of bile duct with contrast |
| Duct contrast radiography NOS |
Plain X-ray of bile duct with contrast |
| ductusektasi |
Dilatation |
| duktalt carcinoma in situ iht. kategori |
Non-infiltrating intraductal carcinoma |
| Duke's (Filatow) sygdom |
Rubeola scarlatinosa |
| Dundee cardiovascular risk score |
Dundee Coronary Risk Disk (assessment scale) |
| Duodenalt ulcus, ikke nærmere specificeret |
Ulcer of duodenum (disorder) |
| Duodenal ulcer NOS |
Ulcer of duodenum (disorder) |
| Duodenitis caused by ingestible alcohol |
Duodenitis caused by ethanol (disorder) |
| Duodenoscopy: [diagnostic NOS] or [NEC] |
Duodenoscopy |
| Duplicate concept |
A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept. |
| rapport i to eksemplarer |
Duplicate report (record artifact) |
| deling ifm. Duputytrens kontraktur |
Dupuytren contracture corrected by division of palmar aponeurosis |
| Dupuytrens kontraktur af finger/fingre, noduli uden kontraktur |
Dupuytren's disease of finger |
| Dupuytrens kontraktur i håndflade med noduli uden kontraktur |
Dupuytren's disease of palm |
| Dværgvækst, ikke klassificeret andetsteds |
Short stature disorder |
| Dværgvækst, ikke klassificeret andetsteds, ikke nærmere specificeret |
Short stature disorder |
| Dwarfism, NEC |
Short stature disorder |
| Dyclonine hydrochloride 1% topical solution (product) |
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| dynamit |
Dynamite stick (physical object) |
| dyphyllin 100 mg + guaifenesin 100 mg eliksir |
Product containing precisely diprophylline 6.67 milligram/1 milliliter and guaifenesin 6.67 milligram/1 milliliter conventional release oral solution (clinical drug) |
| dyphyllin 160 mg/15 ml eliksir |
Diprophylline 10.7 mg/mL oral solution |
| Dyskinesia of esophagus |
Diffuse spasm of esophagus |
| Dysmnesianfald |
An epileptic seizure originating within networks limited to one hemisphere, initially manifesting with impairment of memory, regardless of whether aware or with impaired awareness. This can manifest as déjà vu or jamais vu. |
| Dyssegmental dysplasia with glaucoma syndrome |
Rolland-Debuqois syndrome |
| Dyssocial behavior of child or adolescent |
Dyssocial behavior of child or adolescent (finding) |
| Dysthyroid ophthalmopathy |
Exophthalmos due to thyroid eye disease (disorder) |
| e-mail-rapport |
Email report (record artifact) |
| ECG - general - NOS |
Electrocardiographic procedure |
| ECG equivocal |
ECG equivocal |
| ECG: F wave NOS |
ECG waveform |
| ECG: LVH NOS |
Electrocardiographic left ventricle hypertrophy (finding) |
| ECG: P wave NOS |
P wave - finding |
| ECG: PR interval NOS |
PR interval - finding |
| ECG: Q wave NOS |
Q wave - finding |
| ECG: Q-T interval NOS |
QT interval - finding |
| ECG: QRS complex NOS |
Finding of electrocardiogram QRS complex (finding) |
| ECG: R wave NOS |
R wave - finding |
| ECG: RVH NOS |
ECG: right ventricle hypertrophy |
| ECG: S wave NOS |
S wave - finding |
| ECG: S-T interval NOS |
ST segment - finding |
| ECG: T wave NOS |
T wave - finding |
| ECG: U wave NOS |
U wave - finding |
| ECG: ectopic beats NOS |
ECG: ectopic beats |
| ECG: heart block NOS |
ECG: heart block |
| ECG: left ventricular strain |
ECG: left ventricular strain |
| ECG: myocardial infarct NOS |
ECG: myocardial infarction |
| ECG: myocardial ischaemia NOS |
ECG myocardial ischaemia |
| ECG: supraventric. arryth. NOS |
ECG: supraventricular arrhythmia |
| ECG: ventricular arrhythmia NOS |
Electrocardiographic ventricular arrhythmia (finding) |
| ENT dis. monitoring NOS |
ENT disorder monitoring |
| ENT swab taken NOS |
ENT swab taken |
| ERCP &/or Endoscopic sphincterotomy of sphincter of Oddi and removal of calculus |
ERCP (endoscopic retrograde cholangiopancreatography) sphincterotomy of sphincter of Oddi and calculus removal |
| Ear discharge symptom NOS |
Ear discharge symptoms |
| Ear discharge symptom NOS |
Ear discharge symptoms |
| Ear disorder NOS |
Disorder of ear |
| Ear disorder NOS |
Disorder of ear |
| Ear flap |
Flap (substance) |
| Ear operations NOS |
Operation on the ear |
| Ear operations NOS |
Operation on the ear |
| Ear sign or symptom |
Ear and auditory finding |
| røntgenundersøgelse af ørets bløddele |
Plain X-ray of soft tissue of external ear |
| Ear soft tissue X-ray |
Plain X-ray of soft tissue of external ear |
| Ear, nose and throat disorder monitoring NOS |
ENT disorder monitoring |
| Ear, nose and throat swab taken NOS |
ENT swab taken |
| Ear/nose/throat symptom NOS |
Ear, nose and throat finding (finding) |
| Ear/nose/throat symptom NOS |
Ear, nose and throat finding (finding) |
| Ear/nose/throat symptoms NOS |
Ear, nose and throat finding (finding) |
| Ear/nose/throat symptoms NOS |
Ear, nose and throat finding (finding) |
| Pauciartikulær kronisk artrit med tidlig debut |
Oligoarticular juvenile idiopathic arthritis (JIA) affects between one and up to a maximum of four joints. |
| Early operation NOC NOS |
Intentional, structural alteration of the human body by mechanical, thermal, light-based, electromagnetic, or chemical means, and/or by the incision or destruction of tissues using instruments to cut, burn, vaporize, freeze, suture, probe, or manipulate by closed reductions. |
| Early operation NOC OS |
Intentional, structural alteration of the human body by mechanical, thermal, light-based, electromagnetic, or chemical means, and/or by the incision or destruction of tissues using instruments to cut, burn, vaporize, freeze, suture, probe, or manipulate by closed reductions. |
| Early operations NOC |
Intentional, structural alteration of the human body by mechanical, thermal, light-based, electromagnetic, or chemical means, and/or by the incision or destruction of tissues using instruments to cut, burn, vaporize, freeze, suture, probe, or manipulate by closed reductions. |
| spisevane |
Eating behavior and appetite |
| Ebolavirus |
Genus Ebolavirus (organism) |
| Ebola virus Ivory Coast subtype |
Ivory Coast ebolavirus (organism) |
| Ebola virus Reston biotype |
Reston ebolavirus (organism) |
| Ebola virus Sudan biotype |
Sudan ebolavirus (organism) |
| Ebola virus Zaire biotype |
Zaire virus (organism) |
| Ebola virus disease |
Ebola virus disease |
| ekkrint papillært adenokarcinom |
Digital papillary adenocarcinoma |
| Echinococcus granulosus infection of other site |
Echinococcus granulosus infection |
| Echinococcus multilocularis infection of other site |
Echinococcus multilocularis infection |
| Echinocyte |
Burr cell |
| kontraststof til ekkokardiografi |
Contrast media (substance) |
| Ekkokardiografi til bestemmelse af tykkelsen af det interventrikulære septum |
Echocardiography |
| Ekkokardiografi til bestemmelse af tykkelsen af venstre ventrikels bagvæg |
Ventricular echocardiography |
| Ekkokardiografi til bestemmelse af ventrikelkontraktion |
Echocardiography |
| echothiophatjodid 0,03 % øjendråber |
Ecothiopate iodide 300 microgram/mL eye solution |
| echothiophatjodid 0,06 % øjendråber |
Product containing precisely ecothiopate iodide 600 microgram/1 milliliter conventional release eye solution (clinical drug) |
| echothiophatiodid 0,125 % opløsning |
Ecothiopate (as ecothiopate iodide) 1.25 mg/mL eye solution |
| echothiophatjodid 0,25 % øjendråber |
Ecothiopate iodide 2.5 mg/mL eye solution |
| eklampsi, barn født med postnatal komplikation |
Eclampsia |
| Eklampsi med postnatal komplikation |
Eclampsia |
| econazolnitrat 150 mg/1 % vagitorier + creme |
Econazole only product |
| Economic milestone NOS |
Economic milestone |
| Økonomisk milepæl, ikke nærmere specificeret |
Economic milestone |
FHIR